University Of Athens
Clinical trials sponsored by University Of Athens, explained in plain language.
-
Can a diabetes drug help hearts heal better after a heart attack?
Disease control Recruiting nowThis study looks at whether empagliflozin, a medicine used for diabetes, can help blood vessels and heart muscle recover after a heart attack. About 80 people who had a severe heart attack will either receive empagliflozin or standard care. Researchers will measure artery stiffne…
Sponsor: University of Athens • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a diabetes drug duo protect your heart?
Disease control Recruiting nowThis study looks at whether combining two common diabetes drugs (GLP-1 agonists and SGLT2 inhibitors) can improve heart function and artery health in people with type 2 diabetes who are at high risk for heart problems. About 240 adults will be split into four groups, each receivi…
Sponsor: University of Athens • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New study probes hidden heart risk from common blood fat
Knowledge-focused Recruiting nowThis study looks at how a type of fat in the blood called lipoprotein(a), or Lp(a), affects the stiffness of arteries, the health of blood vessel linings, and the heart's ability to pump. Researchers will follow 300 adults for one year, measuring these factors and tracking heart …
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC